Issue 6/2018
Content (14 Articles)
Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats
Yi Zhou, Huanyuan Wang, Fuli Man, Zhiying Guo, Jiahui Xu, Wenjing Yan, Jiaying Li, Qi Pan, Wen Wang
Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
Yumei Ye, Xiaoming Jia, Mandeep Bajaj, Yochai Birnbaum
Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients
Vasilios Simopoulos, Athanasios Hevas, Apostolia Hatziefthimiou, Konstantina Dipla, Ioannis Skoularigis, Nikolaos Tsilimingas, Isaac Aidonidis
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
Paolo Zocca, Marlies M. Kok, Liefke C. van der Heijden, Peter W. Danse, Carl E. Schotborgh, Martijn Scholte, Marc Hartmann, Gerard C. M. Linssen, Carine J. M. Doggen, Clemens von Birgelen
Heart Failure with Preserved Ejection Fraction Trials Have Heterogeneous Control Groups: a Comparison of Kaplan-Meier Curves
Hongxing Luo, Cong Zhang, Juntao Wang, Jialu Zhu, Xingtai Jia
A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS)
Jianning Zhang, Yijia Shao, Yin Liu, Jun Tao
Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants
Xue Feng, Usha Sambamoorthi, Kim Innes, Gregory Castelli, Traci LeMasters, Lianjie Xiong, Michael U. Williams, Xi Tan
Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction
Lisandro D. Colantonio, Luqin Deng, Ligong Chen, Michael E. Farkouh, Keri L. Monda, David J. Harrison, Juan F. Maya, Meredith L. Kilgore, Paul Muntner, Robert S. Rosenson
Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome
Vijayapraveena Paruchuri, Juan Gaztanaga, Vikash Rambhujun, Robin Smith, Michael E. Farkouh
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
S. Bouchez, F. Fedele, G. Giannakoulas, F. Gustafsson, V.-P. Harjola, K. Karason, M. Kivikko, D. von Lewinski, F. Oliva, Z. Papp, J. Parissis, Piero Pollesello, G. Pölzl, C. Tschöpe
Use of Fentanyl During Percutaneous Coronary Interventions: Safety and Drawbacks
Marco Zuin, Gianluca Rigatelli, Loris Roncon
Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?
Rosa Ahn, Vinay Prasad
Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?
Rosa Ahn, Vinay Prasad
Publisher Correction: Exposure to Stress-Dose Steroids and Lethal Septic Shock After In-Hospital Cardiac Arrest: Individual Patient Data Reanalysis of Two Prior Randomized Clinical Trials that Evaluated the Vasopressin–Steroids–Epinephrine Combination Versus Epinephrine Alone
Spyros D. Mentzelopoulos, Iosifina Koliantzaki, Marios Karvouniaris, Charikleia Vrettou, Nicolas Mongardon, George Karlis, Demosthenes Makris, Epaminondas Zakynthinos, Sotirios Sourlas, Stavros Aloizos, Theodoros Xanthos, Spyros G. Zakynthinos